Status of Immunotherapy Acceptance in Chinese Patients With Multiple Sclerosis: Analysis of Multiple Sclerosis Patient Survival Report 2018

Ran Zhou(Central South University), Weihong Zheng, Manxia Wang(Lanzhou University Second Hospital), Jinzhou Feng(The Affiliated Yongchuan Hospital of Chongqing Medical University), Meini Zhang(Shanxi Medical University), Qiuming Zeng(University of Iowa), Aiyu Lin(Fujian Medical University), Tao Jin(Jilin University), Xinghu Zhang(National Clinical Research Center for Digestive Diseases), Chun‐Sheng Yang(Tianjin Medical University General Hospital), Huan Yang, Weibin Liu(Sun Yat-sen University), Bitao Bu(Tongji Hospital), Youming Long(Second Affiliated Hospital of Guangzhou Medical University), Hongyu Zhou(Sichuan University), Lihua Wang(Jiangxi University of Traditional Chinese Medicine), Huiqing Dong(Capital Medical University), Min Zhang(Shanxi Medical University), Zhe Wang(Chinese Academy of Sciences), Xu Zhang(Huizhou Central People's Hospital), Yan Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Guojun Tan, Yulan Tang(Guangxi Medical University), Feng Gao(Peking University), Honghao Wang(Southwest Jiaotong University), Lei Wu, Hongbo Liu(First Affiliated Hospital of Zhengzhou University), Chunyang Li(Jiangsu Academy of Agricultural Sciences), Jiawei Wang(Qilu University of Technology)
Frontiers in Neurology
April 8, 2021
Cited by 13


Related Papers